Navigation Links
Horst Sievert, M.D., Ph.D. presented with Master Clinical Operator Award at TCT 2011
Date:11/11/2011

SAN FRANCISCO, CA NOVEMBER 11, 2011 Horst Sievert, MD, PhD, a renowned interventional cardiologist, was presented the TCT 2011 Geoffrey O. Hartzler Master Clinical Operator Award in a ceremony held today during the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF). The award is given each year to a physician who has advanced the field of interventional cardiovascular medicine through technical excellence and innovation.

Dr. Sievert is known for his expertise in highly specialized non-coronary interventions for patients with congenital heart disease, carotid disease, or a high risk of stroke. Dr. Sievert was the first to close the left atrial appendage percutaneously and has the greatest experience worldwide in catheter closure of heart defects in adults. Over the course of his career, Dr. Sievert has personally performed more than 25,000 percutaneous coronary interventions and 12,000 peripheral angioplasties as well as more than 5,000 structural and valvular interventions.

In addition to serving as the principal investigator of a number of clinical trials, Dr. Sievert has authored more than 200 manuscripts and 600 abstracts in peer reviewed journals, as well as 100 books and book contributions. He has also delivered more than 1,000 invited lectures around the world.

TCT Directors, Martin B. Leon, MD and Gregg W. Stone, MD jointly presented the award, which recognizes technical skill and expertise. Dr. Leon is the Founder of CRF and Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Dr. Stone is Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center. Both serve as Co-Directors of the Medical Research and Education Division at CRF.

"We are proud to honor Dr. Sievert with the TCT 2011 Geoffrey O. Hartzler Master Clinical Operator Award," said Dr. Stone. "His unparalleled technical expertise in highly specialized non-coronary interventions and catheter closures for heart defects in adults has helped to expand the field of interventional cardiovascular medicine and provided physicians with new, more effective ways to treat patients."

"Dr. Sievert continues to develop innovative techniques and devices for patients with cardiovascular disease, in addition to serving as mentor and teacher to the next generation of interventional cardiologists," Dr. Leon added.


'/>"/>

Contact: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. Register Online for this Year's Horst Senior Living Conference on April 8 Featuring Keynote Speaker and Senior Housing Expert Jim Moore
2. Andrew J. Dannenberg, M.D., honored with AACR-Prevent Cancer Foundation Award
3. UCSF neurologist William Seeley, M.D., named MacArthur Fellow
4. Dale Browne, M.D., ear, nose, and throat specialist, receives award from National Medical Society
5. Ching-Hon Pui, M.D., honored by the American Society of Hematology for work in childhood cancer
6. BUS Jeffrey H. Samet, M.D., selected as a 2011 NIDA International Program Awards of Excellence winner
7. Mayo Clinic: Raoul Tibes, M.D., Ph.D., to receive Career Development Award
8. BIDMCs Peter Weller, M.D., receives NIH MERIT Award
9. BIDMC neurologist Bernard Chang, M.D., receives award for epilepsy research
10. Alfred B. Knight, M.D., Scott & White Healthcare, presents at 8th Annual World Health Care Congress
11. Ching-Hon Pui, M.D., recognized with American Association for Cancer Research award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... As part of their 2015 end of year ... Table Foundation (MDRTF), has gifted $10,000 to University of Chicago to support ovarian cancer ... Cundiff. , “We are honored to support a promising young investigator from Dr. Lengyel’s ...
(Date:2/10/2016)... ... February 10, 2016 , ... The ... World Molecular Imaging Congress (WMIC), will be held in New York City, NY ... “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging reveals a ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Early this week, ... and raise awareness of Nestlé KITKAT as the first global confectionery brand sourced from ... cocoa farmers and the quality of their product, through activities that focus on better ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... care communications company offering education, research and medical media, has launched ... working in infectious diseases. , As the all-inclusive resource for infectious disease ...
(Date:2/10/2016)... Walton Beach, Florida (PRWEB) , ... February 10, ... ... the innovative weather-forecasting company is unveiling its revolutionary new 2.0 version at the ... platform, MetLoop has “put the power of the world's most advanced weather technology ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... fourth quarter and full year ended December 31, 2015. ... was a transformational year for Vanda with the continued ... market approval of HETLIOZ for Non-24," said Mihael H. ... Fanapt to our U.S. product portfolio builds on this ...
(Date:2/10/2016)... , February 10, 2016 ... Analyzers (Liquid & Gas), and Spectroscopy Market by Industry (Oil ... Beverage, Pulp & Paper, Metal & Mining, and Others), ... MarketsandMarkets, the global market is expected to grow to ... of 8.6% between 2015 and 2020. Browse ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
Breaking Medicine Technology: